treatment
-
Disability Support & Independent Living
FDA Withdraws Approval of Wellcovorin, GSK’s Branded Leucovorin, Amidst Complex History of Autism Treatment Claims
United States regulators have formally withdrawn the Food and Drug Administration’s (FDA) approval for Wellcovorin, the branded version of leucovorin…
Read More » -
Alzheimer’s & Dementia Care
Health Canada Conditionally Approves Leqembi, Marking a Pivotal Shift in Alzheimer’s Treatment by Targeting Underlying Disease Cause
Health Canada has granted conditional approval for Leqembi (lecanemab), a groundbreaking therapy co-developed by Eisai and Biogen, for specific adults…
Read More » -
Palliative & Hospice Care
Alzheimer’s Disease, Amyloid, and Antibodies: Experts Grapple with Evolving Definitions and Treatment Dilemmas
The landscape of Alzheimer’s disease diagnosis and treatment is undergoing a profound transformation, driven by advancements in understanding the disease’s…
Read More » -
Alzheimer’s & Dementia Care
FDA Reviews Expanded Approval for Leqembi Iqlik: Subcutaneous Option for Early Alzheimer’s Treatment Initiation
The U.S. Food and Drug Administration (FDA) is currently reviewing a supplemental Biologics License Application (sBLA) seeking expanded approval for…
Read More » -
Palliative & Hospice Care
Palliative Care: A Beacon of Hope Amidst the Spectrum of Cancer Treatment
The landscape of cancer treatment often presents patients and their families with a stark dichotomy: the fervent hope for a…
Read More »